Literature DB >> 27931142

The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study.

Ricardo Closa-Monasterolo1,2, Natalia Ferré2, Gemma Castillejo-DeVillasante2,3, Veronica Luque1,2, Mariona Gispert-Llaurado2, Marta Zaragoza-Jordana2, Stephan Theis4, Joaquin Escribano2,4.   

Abstract

BACKGROUND: Constipation is a common disorder in children.
OBJECTIVE: The objective of this study is to assess the beneficial effects of a daily supplementation with Orafti® inulin-type fructans in 2-5 year old constipated children.
METHODS: Double-blind, randomised, placebo-controlled parallel group trial where constipated children received two doses of 2 g Orafti® inulin-type fructans (OF:IN) or placebo (maltodextrin) for 6 weeks. Primary outcome was stool consistency. Secondary outcomes were stool frequency and gastrointestinal symptoms.
RESULTS: Twenty-two children were included, 17 completed the study protocol (nine and eight for the control and the OF:IN group, respectively). Results showed that Orafti® inulin-type fructans supplemented children had softer stools (p = .003). The longitudinal analysis showed no significant changes in controls, whereas supplemented children increased their stool consistency from 2.2 to 2.6 on the modified Bristol scale for children (five items instead of seven) (p = .040).
CONCLUSIONS: Prebiotic inulin-type fructans supplementation improves stool consistency in constipated 2-5-year old children. Clinicaltrials.gov, with number NCT02863848.

Entities:  

Keywords:  Constipation; children; inulin; non-pharmacological treatment; prebiotics; stool consistency

Mesh:

Substances:

Year:  2016        PMID: 27931142     DOI: 10.1080/09637486.2016.1263605

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  11 in total

Review 1.  Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

Authors:  Glenn R Gibson; Robert Hutkins; Mary Ellen Sanders; Susan L Prescott; Raylene A Reimer; Seppo J Salminen; Karen Scott; Catherine Stanton; Kelly S Swanson; Patrice D Cani; Kristin Verbeke; Gregor Reid
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-14       Impact factor: 46.802

Review 2.  Traditional, complementary and alternative medicine in children constipation: a systematic review.

Authors:  Maryam Sadat Paknejad; Monireh Sadat Motaharifard; Shahdis Barimani; Payam Kabiri; Mehrdad Karimi
Journal:  Daru       Date:  2019-11-16       Impact factor: 3.117

3.  Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans.

Authors:  Samuel M Lancaster; Brittany Lee-McMullen; Charles Wilbur Abbott; Jeniffer V Quijada; Daniel Hornburg; Heyjun Park; Dalia Perelman; Dylan J Peterson; Michael Tang; Aaron Robinson; Sara Ahadi; Kévin Contrepois; Chia-Jui Hung; Melanie Ashland; Tracey McLaughlin; Anna Boonyanit; Aaron Horning; Justin L Sonnenburg; Michael P Snyder
Journal:  Cell Host Microbe       Date:  2022-04-27       Impact factor: 31.316

4.  Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis.

Authors:  Annabel Biruete; Andrea Shin; Brandon M Kistler; Sharon M Moe
Journal:  Semin Dial       Date:  2021-10-27       Impact factor: 2.886

5.  The Effect of Glycosylated Soy Protein Isolate on the Stability of Lutein and Their Interaction Characteristics.

Authors:  Xia Wang; Shaojia Wang; Duoxia Xu; Jingwei Peng; Wei Gao; Yanping Cao
Journal:  Front Nutr       Date:  2022-05-24

6.  Inulin-Type Fructan Supplementation of 3- to 6-Year-Old Children Is Associated with Higher Fecal Bifidobacterium Concentrations and Fewer Febrile Episodes Requiring Medical Attention.

Authors:  Szimonetta Lohner; Viktória Jakobik; Krisztina Mihályi; Sara Soldi; Sotirios Vasileiadis; Stephan Theis; Manuela Sailer; Carolin Sieland; Károly Berényi; Günther Boehm; Tamás Decsi
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

7.  The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children.

Authors:  Cara Hannah Axelrod; Miguel Saps
Journal:  Nutrients       Date:  2018-11-03       Impact factor: 5.717

8.  Effects of Infant Formula Supplemented With Prebiotics and OPO on Infancy Fecal Microbiota: A Pilot Randomized Clinical Trial.

Authors:  Bingquan Zhu; Shuangshuang Zheng; Kexin Lin; Xin Xu; Lina Lv; Zhengyan Zhao; Jie Shao
Journal:  Front Cell Infect Microbiol       Date:  2021-03-29       Impact factor: 5.293

9.  Aloe barbadensis Mill. extract improves symptoms in IBS patients with diarrhoea: post hoc analysis of two randomized double-blind controlled studies.

Authors:  Bani Ahluwalia; Maria K Magnusson; Lena Böhn; Stine Störsrud; Fredrik Larsson; Lena Öhman; Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2021-10-08       Impact factor: 4.409

10.  Lactobacillus reuteri DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial.

Authors:  Andrea A García Contreras; Edgar M Vásquez Garibay; Carmen A Sánchez Ramírez; Mary Fafutis Morris; Vidal Delgado Rizo
Journal:  Nutrients       Date:  2020-09-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.